EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

3D bioprinting in tissue engineering: current state-of-the-art and challenges towards system standardization and clinical translation

Tarun Agarwal iD, Valentina Onesto iD, Dishary Banerjee, Shengbo Guo, Alessandro Polini iD, Caleb Vogt iD, Abhishek Viswanath, Timothy Esworthy, Haitao Cui, Aaron O'Donnell, Kiran Yellappa Vajanthri, Lorenzo Moroni iD und 5 weitere

Biofabrication · 01.10.2025 · 17 (4) · 042003

DOI: 10.1088/1758-5090/ade47a ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biofabrication, online erschienen am 07.08.2025. Verfasst von Tarun Agarwal und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical and Aerospace Engineering, The George Washington University, Washington, DC 20052, United States of America. Hauptthemen laut MEDLINE: Tissue Engineering, Bioprinting, Printing, Three-Dimensional. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 273 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past decade, three-dimensional (3D) bioprinting has made significant progress, transforming into a key innovation in tissue engineering. Despite the early strides, critical challenges remain in 3D bioprinting that must be addressed to accelerate clinical translation. In particular, there is still a long way to go before functionally-mature, clinically-relevant tissue equivalents are developed. Current limitations range from the sub-optimal bioink properties and degree of biomimicry of bioprintable architectures, to the lack of stem/progenitor cells for massive cell expansion, and fundamental knowledge regarding in vitro culturing conditions. In addition to these problems, the absence of guidelines and well-regulated international standards is creating uncertainty among the biofabrication community stakeholders regarding the reliable and scalable production processes. This review aims at exploring the latest developments in 3D bioprinting approaches, including various additive manufacturing techniques and their applications. A thorough discussion of common bioprinting techniques and recent progresses are compiled along with notable recent studies. Later we discuss the current challenges in clinical application of 3D bioprinting and the major bottlenecks in the commercialization of 3D bioprinted tissue equivalents, including the longevity of bioprinted organs, meeting biomechanical requirements, and the often underrated ethical and legal aspects. Amidst the progress of regulatory efforts for regenerative medicine, we also present an overview of the current regulatory concerns which should be taken into account to translate bioprinted tissues into clinical practice. At last, this review emphasizes future directions in 3D bioprinting that includes the transformative ideas such as bioprinting in microgravity and the integration of artificial intelligence. The study concludes with a discussion on the need for collaborative efforts in resolving the technical and regulatory constraints to improve the quality, reliability, and reproducibility of bioprinted tissue equivalents to ultimately accomplish their successful clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tissue EngineeringBioprintingPrinting, Three-DimensionalHumansAnimalsTissue Scaffolds

Stichwörter der Autor:innen

3D bioprinting4D bioprintingbioinksbiomaterialstissue engineering

Autor:innen und Institutionen

  • Department of Mechanical and Aerospace Engineering, The George Washington University, Washington, DC 20052, United States of America.
  • Center for Advanced Biomaterials for Health Care, Istituto Italiano di Tecnologia (IIT@CRIB), Naples 80125, Italy.
  • Engineering Science and Mechanics Department, The Pennsylvania State University, University Park, PA, United States of America.
  • Department of Cardiovascular Research, School of Medicine, University of California San Diego, La Jolla, CA 92093, United States of America.
  • Institute of Nanotechnology, National Research Council (CNR-NANOTEC), Campus Ecotekne, via Monteroni, Lecce 73100, Italy.
  • Medical Scientist Training Program, University of Minnesota-Twin Cities, Minneapolis, MN 55455, United States of America.

ORCID-Profile: Tarun Agarwal, Valentina Onesto, Alessandro Polini, Caleb Vogt, Lorenzo Moroni, Ibrahim T Ozbolat, Angela Panoskaltsis-Mortari, Lijie Grace Zhang, Marco Costantini, Tapas Kumar Maiti

Förderung

  • NHLBI NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Agarwal, T., Onesto, V., Banerjee, D., Guo, S., Polini, A., Vogt, C., Viswanath, A., Esworthy, T., Cui, H., O'Donnell, A., Vajanthri, K. Y., Moroni, L., Ozbolat, I. T., Panoskaltsis-Mortari, A., Zhang, L. G., Costantini, M., & Maiti, T. K. (2025). 3D bioprinting in tissue engineering: current state-of-the-art and challenges towards system standardization and clinical translation. Biofabrication, 17(4), 042003. https://doi.org/10.1088/1758-5090/ade47a

Vancouver

Agarwal T, Onesto V, Banerjee D, Guo S, Polini A, Vogt C, et al. 3D bioprinting in tissue engineering: current state-of-the-art and challenges towards system standardization and clinical translation. Biofabrication. 2025;17(4):042003. doi:10.1088/1758-5090/ade47a

BibTeX
@article{Agarwal2025,
  author = {Agarwal, Tarun and Onesto, Valentina and Banerjee, Dishary and Guo, Shengbo and Polini, Alessandro and Vogt, Caleb and Viswanath, Abhishek and Esworthy, Timothy and Cui, Haitao and O'Donnell, Aaron and Vajanthri, Kiran Yellappa and Moroni, Lorenzo and Ozbolat, Ibrahim T and Panoskaltsis-Mortari, Angela and Zhang, Lijie Grace and Costantini, Marco and Maiti, Tapas Kumar},
  title = {3D bioprinting in tissue engineering: current state-of-the-art and challenges towards system standardization and clinical translation},
  journal = {Biofabrication},
  year = {2025},
  volume = {17},
  number = {4},
  pages = {042003},
  doi = {10.1088/1758-5090/ade47a}
}
Kostenlos starten →